Abadan, Xia Claire P.
HRN: 20-93-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/25/2024
01/28/2024
PO
5ml
BID
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes